Refresh

Samrat Pharmachem Ltd. - Research Center

530125 SAMRATPH Group (X) BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20 Mar ' 19
Income

Operating income

310.65 221.81 179.02 137.45 111.14
Expenses

Material consumed

277.87 189.90 164.25 125.62 102.62

Manufacturing expenses

4.01 3.77 2.86 2.24 2.19

Personnel expenses

1.88 1.77 1.50 1.44 1.38

Selling expenses

0.01 0.02 0.04 0.02 0.01

Adminstrative expenses

2.96 2.00 1.70 1.51 1.75

Expenses capitalised

- - - - -

Cost of sales

286.72 197.47 170.35 130.82 107.96

Operating profit

23.93 24.34 8.67 6.63 3.18

Other recurring income

0.48 0.55 0.46 0.57 0.46

Adjusted PBDIT

24.41 24.89 9.13 7.20 3.63

Financial expenses

1.23 0.67 1.28 0.98 1.06

Depreciation

0.64 0.59 0.49 0.43 0.42

Other write offs

- - - - -

Adjusted PBT

22.53 23.62 7.36 5.80 2.16

Tax charges

5.90 6.42 2.01 1.55 0.62

Adjusted PAT

16.63 17.21 5.35 4.25 1.54

Non recurring items

- -0.02 -0.02 -0.01 -

Other non cash adjustments

- - - - -

Reported net profit

16.63 17.18 5.33 4.24 1.54

Earnigs before appropriation

60.36 43.73 26.55 21.21 16.98

Equity dividend

0.31 - - - -

Preference dividend

- - - - -

Dividend tax

- - - - -

Retained earnings

60.05 43.73 26.55 21.21 16.98
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com